Effectiveness of a Postal Intervention to Improve the Use of PPI
NCT03840018 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 401
Last updated 2019-02-15
Summary
It was a randomised intervention study, with before-and-after outcome measures and a control group, in patients who had an active long-term prescription for PPIs at high doses for at least 6 months.
Conditions
- Drug Overdose
Interventions
- OTHER
-
Letter by post to patients
Patients received an informative letter by post, in which their doctor invited them to seek an appointment for a medication review
Sponsors & Collaborators
-
Osakidetza
lead OTHER
Principal Investigators
-
Elena Valverde · Osakidetza
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-10
- Primary Completion
- 2017-12-10
- Completion
- 2018-04-18
Countries
- Spain
Study Locations
More Related Trials
-
On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication
NCT00161096 ·Status: UNKNOWN ·Phase: PHASE3
-
PPI Test in GP Patients
NCT00318084 ·Status: COMPLETED ·Phase: PHASE4
-
PPI-Rebound-Trial. A Study of the Clinical Relevance of the Acid Rebound Phenomena
NCT00526006 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Study To Investigate The Association Between Acid Control And Heartburn Symptoms After Proton Pump Inhibitor Treatment
NCT02708355 ·Status: COMPLETED ·Phase: PHASE4
-
Strategies for Improving Proton Pump Inhibitors (PPIs) Prescription Associated to Non-steroidal Anti-inflammatory Drugs (NSAIDs)
NCT01128127 ·Status: WITHDRAWN ·Phase: NA
-
Proton Pump Inhibitor Treatment Stop
NCT00120315 ·Status: COMPLETED ·Phase: PHASE4
-
High Versus Standard Dose of Proton Pump Inhibitors (PPIs) in Peptic Ulcer Bleeding
NCT00374101 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population
NCT03467893 ·Status: COMPLETED
-
Proton Pump Inhibitor (PPI) Inappropriate Use and Economic Burden in Chinese Population
NCT03118778 ·Status: COMPLETED
-
Deprescribing Inappropriate Proton Pump Inhibitors
NCT06129474 ·Status: RECRUITING ·Phase: NA
-
Inappropriate Prescribing of Proton-pump Inhibitor is it Associated With the Burden of Comorbidities in Older Patients?
NCT02841852 ·Status: COMPLETED
-
Proton Pump Inhibitor (PPI, Rabeprazole) Effect On Tablet Formulation Of Palbociclib
NCT03220191 ·Status: COMPLETED ·Phase: PHASE1
-
CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor Testing
NCT00354757 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Significance of Acid Rebound in Functional Dyspepsia
NCT01373970 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers
NCT03163680 ·Status: COMPLETED
-
Proton Pump Inhibitors (PPI): a Study to Improve Appropriate Prescriptions in the Elderly
NCT04637750 ·Status: COMPLETED ·Phase: NA
-
Smartphone App-assisted PPI
NCT06094062 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Effect of Increased Gastric pH on the Oral Bioavailability of the Orexin-2 Receptor Antagonist JNJ-42847922 in Healthy Participants
NCT02475161 ·Status: COMPLETED ·Phase: PHASE1
-
PPI Sequencing Study
NCT00384592 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease
NCT00829738 ·Status: COMPLETED
-
Evaluation of the National Randomized Proton Pump Inhibitor De-prescribing (RaPPID) Program
NCT03719170 ·Status: COMPLETED ·Phase: NA
-
Inventory of Inappropriate Prescriptions of Proton Pump Inhibitors (PPIs) in People Over 75 Years of Age
NCT05618249 ·Status: COMPLETED
-
PPI And Food Effect Study For PF-06463922 In Healthy Volunteers
NCT02569554 ·Status: COMPLETED ·Phase: PHASE1
-
Symptom Control Satisfaction With Proton Pump Inhibitor Regimen
NCT02623816 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535 ·Status: COMPLETED ·Phase: PHASE3